StockData
Scinai Immunotherapeutics Ltd. logo

Scinai Immunotherapeutics Ltd. (SCNI) stock

SCNINasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Apr 1, 2026Score 6/30
$0.37−0.03 (-7.82%)

Close on Nov 17, 2026Market cap $1.29MP/E –Yield –

Scinai Immunotherapeutics EPS

Diluted earnings per share is net income divided by the share count including options and convertible securities.

For fiscal 2023 it was $0.00, down 60.0% from the year before. The highest annual figure on record is $0.01 in fiscal 2022.

Annual eps

PeriodPeriod endValueChange
FY2023Dec 31, 2023$0.00-60.0%
FY2022Dec 31, 2022$0.01–
FY2021Dec 31, 2021-$0.02–
FY2019Dec 31, 2019-$0.33–
FY2017Dec 31, 2017-$0.05–

Quarterly eps

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2023Jun 30, 2023-$0.00-103.0%
Q1 FY2023Mar 31, 2023-$0.00–
Q2 FY2022Jun 30, 2022-$0.00–
Q1 FY2022Mar 31, 2022-$0.00–
Q3 FY2020Sep 30, 2020$0.10–
Q3 FY2019Sep 30, 2019-$0.05–

More Scinai Immunotherapeutics figures

See a number that looks wrong?